Acrux (ASX:ACR) is continuing to advance its Female Testosterone programme, with the FDA providing a clear pathway toward late-stage clinical trials and global pharmaceutical companies showing strong interest in partnering on its product. Alongside this, the company`s commercial business continues to generate cash, funding development of what management describes as a once-in-a-generation opportunity in women`s health. CEO & Managing Director John Warmbrunn joins The Stock Network`s Lel Smits to discuss the June quarter, the Female Testosterone opportunity, growing commercial momentum and the key milestones ahead.

⚕️ Female Testosterone progress and US FDA
🎗️ A major opportunity in women`s health
🚀 Commercial catalysts

Impact Minerals (ASX:IPT) has advanced its Lake Hope High Purity Alumina (HPA) Project toward a Definitive Feasibility Study, with the pilot plant programme now underway at Edith Cowan University. During the last quarter, joint venture partner Kuniko (ASX:KNI) also intersected mineralisation in every hole at the Commonwealth–Silica Hill Gold-Silver Project, including a new discovery at Silica Hill. Managing Director Dr Mike Jones joins The Stock Network`s Lel Smits to discuss the last quarter`s progress, Lake Hope DFS progress, Commonwealth discover and Commonwealth–Silica Hill catalysts.

🛘 Lake Hope DFS progress
🔍 Commonwealth discovery
🪓 Lake Hope, Salmon Gums and Commonwealth–Silica Hill catalysts

EBR Systems (ASX:EBR) is advancing cardiac resynchronisation therapy with the world’s only leadless pacing technology designed for heart failure patients. The company’s WiSE™ CRT System delivers wireless pacing directly inside the heart, offering an alternative to conventional systems that rely on pacing leads. Dr Anne Kroman, DO, PhD, Director of Electrophysiology Lab and Cardiac Device program at the Medical University of South Carolina, joins The Stock Network’s Lel Smits to discuss where the Coupler fits within the WiSE implant procedure, its role during electrode implantation, and how procedural tools can support physician confidence as more centres adopt the technology.

♥️ Where the Coupler fits within the WiSE implant procedure
🩺 Supporting stability, control and electrode advancement
⚕️ Supporting consistency as WiSE adoption expands

Australia`s richest person, Gina Rinehart, has invested A$7.95 million into an ASX-listed explorer G50 Corp (ASX:G50) through her private company, Hancock Prospecting, as part of a A$26.25 million capital raising.

The investment will see Hancock become a cornerstone shareholder with a stake of around 5.4% while the funds will accelerate drilling and exploration across G50`s Golconda Gold-Silver-Gallium Project in Arizona and White Caps Gold Project in Nevada.

The backing not only strengthens G50`s balance sheet to fast-track exploration but also highlights continued investor appetite for quality gold and critical minerals projects, particularly those located in the United States.

#mining #stocks #ASX #money #investing

Clean TeQ Water (ASX:CNQ) completes commissioning and performance testing of its first full-scale commercial PHOSPHIX® phosphate removal plant in Europe, marking a key commercial milestone for the company`s water treatment technology.

💧 Commercial milestone: The PHOSPHIX® plant, delivered with Enva in Ireland, becomes Clean TeQ Water`s first commercial operating reference in Europe following its successful commissioning and testing.
✅ Performance exceeds targets: Independent laboratory testing showed phosphate concentrations below 0.1 mg/L, exceeding the contractual requirement of 1.0 mg/L by more than tenfold, while the plant also operated above its designed hydraulic capacity.
🌍 Growth platform: The successful deployment provides a commercial reference plant for prospective customers and strengthens Clean TeQ Water`s position to pursue new industrial and municipal phosphate removal opportunities across Europe as environmental regulations tighten.
"Today`s announcement marks the successful commercial deployment of PHOSPHIX® at full industrial scale, consistently delivering phosphate concentrations well below contractual requirements while exceeding design throughput." – Peter Voigt, CEO

ASX announcement ⚡ https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03114823-3A697724&v=undefined

Gwardar Resources has listed on the ASX with the ticker code of GRS. It is a mining explorer that has entered into Acquisition Agreements to wholly acquire the Doolgunna and Kurnalpi Projects located in Western Australia. The Doolgunna Project lies within the Murchison Mineral Field, while the Kurnalpi Project is located within the Eastern Goldfields. The proceeds of Gwardar Resources’ IPO raising will fund initial exploration activities at these projects, both of which are prospective for gold and base metals.

Media: The Stock Network, Lel Smits

Archer Materials (ASX:AXE) advances the development of its Biochip medical diagnostics platform, progressing it towards a clinically deployable device, and expanding its sensing capabilities ahead of planned engagement with the U.S. FDA.

🩺 Clinical development: Archer Materials has commenced industrial design of a clinical-ready potassium testing device, focusing on usability, manufacturability and regulatory readiness as it moves beyond core technology development.
🔬 Technology progress: The Company integrates haemolysis sensing into its Biochip platform, detecting plasma free haemoglobin at clinically relevant levels to help improve the accuracy of point-of-care potassium testing.
💊 Platform expansion: Archer Materials also demonstrates clinically relevant lithium sensing with its Biochip prototype, supporting the platform`s potential for additional point-of-care blood tests beyond potassium monitoring.

"This is an important inflection point for the Company and our Biochip program as we advance qualification and product development in parallel, while continuing to reduce technical risk." – Dr. Simon Ruffell, Archer Materials CEO

Alurion Resources has listed on the ASX with the ticker code of ALU. The company is a demerged entity that owns the Amargosa Bauxite-Gallium Project previously held by Brazilian Rare Earths Limited. This project, located in Bahia, one of Brazil’s established mining states, comes with some 57,000 metres of historical drilling and extensive geological and geophysical datasets. Exploration activities undertaken to date at Amargosa have already delivered a globally significant JORC Mineral Resource Estimate. First stage development of the project will comprise a direct-ship-bauxite operation targeting high-grade gibbsitic bauxite and a Scoping Study base case with attaching average per annum production and mine life metrics.

Media: The Stock Network, @lelsmits